Menu

ABVC BioPharma, Inc. ABVC

Full chart Compare
Set alert

Price alert · ABVC

All alert types
0.97 USD 0.00 (-0.25%)

At closeNov 6, 2026, 4:01 PM EST

0.98 +0.01 +1.35%

After hours · Nov 6, 4:01 PM ET

0.9501 Day range 0.98
0.707 52-week range 3.06
YTD
-54.52%
1 year
-65.89%

Revenue & Expenses

Other Income → Expenses: $517.72KIncome Tax Benefit → Expenses: $110.54KExpenses → Selling, General & Admin: $2.26MExpenses → Research & Development: $179.27KExpenses → Other Operating Expenses: $2.77MExpenses → Interest Expense: $825.90KGross Profit → Expenses: $508.83KRevenue → Gross Profit: $508.83KRevenue → Cost of Revenue: $763Net Loss → Expenses: $4.90MOther Income$517.72KIncome Tax Benefit$110.54KGross Profit$508.83KNet Loss$4.90MCost of Revenue$763Expenses$6.04MSelling, General & Admin$2.26MResearch & Development$179.27KOther Operating Expenses$2.77MInterest Expense$825.90KRevenue$509.59K

Latest period ending Dec 31, 2025 · select a line to chart its full history

ABVC annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-7.15M-4.71M-6.77M-15.11M-11.71M
-7.91M-4.90M-7.79M-16.42M-12.84M
-0.39-0.42-1.80-5.19-5.10
ABVC annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.33M863.82K716.78K1.39M6.57M
21.06M7.54M7.78M9.58M13.70M
7.76M6.82M6.53M6.34M4.83M
3.47M2.43M2.60M3.05M3.11M
11.11M1.23M1.55M3.10M8.84M
ABVC annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-2.99M-1.81M-4.19M-7.40M-7.60M
-1.21M0-360.19K-1.72M-805.97K
4.64M1.98M3.87M4.01M10.00M
-5.79K0-21.20K-119.69K-17.50K
463.17K147.03K-674.95K-5.17M1.56M